Analyst Viewpoint
Rise in prevalence of chronic disorders and increase in investment in clinical research are propelling the flow cytometry market trajectory. Flow cytometry is gaining traction in stem cell research to examine the characteristics of mixed cell populations derived from peripheral blood, bone marrow, and solid tissues.
Data interpretation, standardization issues, and high cost associated with advanced flow cytometry equipment are expected to lead to flow cytometry market limitations. R&D of new drugs is likely to offer lucrative opportunities to vendors in the global flow cytometry industry. Key players are investing in advanced technologies and launching new products to expand their portfolio.
Flow cytometry is a technology that is employed in biology and medicine to analyze and sort cells based on their physical and chemical properties. It involves the passage of cells through a laser beam, measuring the scattered and fluorescent light to identify and quantify characteristics such as size and complexity. Using microscopy, about six parameters of a single cell can be detected, whereas flow cytometer instruments can detect up to 30 distinct parameters. Additionally, modern flow cytometers are capable of processing over 10,000 cells per second, thereby, enabling scientists to rapidly analyze and characterize millions of cells.
Flow cytometry plays a major role in diagnosing and finding early signs of immune deficiencies and cancer in patients. Immunophenotyping, biomarker analysis, and disease monitoring are some of the techniques utilized to determine severe chronic conditions.
Surge in prevalence of chronic diseases, such as leishmaniasis, HIV, and cancer amongst individuals is fueling the flow cytometry market development. According to the World Health Organization, cancer was one of the leading causes of death in 2020, accounting for approximately 10 million deaths. The most common types of cancer were breast cancer (2.26 million cases), lung cancer (2.21 million cases), colon and rectum cancer (1.93 million cases), prostate (1.41 million cases), skin (1.20 million cases), and stomach (1.09 million cases).
In April 2022, an article published in the journal Biochemistry Research International stated that Visceral Leishmaniasis (VL), also referred to as kala-azar, affects around 50,000-90,000 individuals globally every year. Thus, high incidence of VL is expected to spur the flow cytometry market growth in the near future. In December 2022, an article published in the journal Tropical Medicine and Infectious Disease discussed how the number of cases of leishmaniasis has been rising over the past five years. Flow cytometry in infectious disease diagnosis is employed to analyze and characterize cells, typically blood cells, to identify and quantify pathogens or abnormal immune responses associated with infections.
Rise in application of flow cytometry in stem cell research is propelling the market revenue. In April 2022, the International Journal of Laboratory Haematology published an article discussing the versatile applications of flow cytometry in examining the characteristics of mixed cell populations derived from peripheral blood (PB), bone marrow (BM), and solid tissues. This method enables the isolation of individual cells for further study.
Flow cytometry is an analytical method utilized in the detection and analysis of physical features of cells or particles during the drug discovery and development process. It has emerged as an important tool for safety and exploratory purposes due to its ability to quickly examine a large number of particles and provide statistically reliable information on the cell population.
R&D of new drugs is driving the flow cytometry market revenue. The need for developing new drugs has led to surge in investment in clinical research. In October 2021, BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson, and Company), collaborated with Christian Medical College (CMC), Vellore, to launch its second Centre of Excellence (CoE) in flow cytometry for clinical research in India. This CoE is expected to serve as the National Reference Center for clinical diagnostics applications, wherein hematologists, physicians, and lab specialists from across India can come together to deliberate and discuss standardization and the best practices in clinical flow cytometry, according to BD Life Sciences.
Availability of digital platform for flow cytometry is fueling the flow cytometry market value.
In July 2021, Becton, Dickinson, and Company introduced a reimagined digital platform for flow cytometry to enhance the online shopping experience for its consumers and procurement teams. The new BD Biosciences marketplace is an online destination that offers BD's research, clinical, and single-cell analysis, and multi-omic products, making it an attractive option for the most in-depth users of flow cytometry.
North America accounted for the largest flow cytometry market share in 2022, led by a rise in leishmaniasis and HIV cases. The increasing prevalence of leishmaniasis and HIV has highlighted the significance of flow cytometry in determining a patient's prognosis. In July 2022, the Government of Canada estimated 62,790 people were living with HIV in Canada from 2020 to 2021. Presence of major players is also driving the market dynamics of North America.
The global flow cytometry market landscape is highly competitive, with several opportunities for expansion and innovation. Flow cytometry companies are adopting various strategies, such as mergers and acquisitions and new product development, to expand their product portfolio.
Becton, Dickinson and Company, Merck & Co., Inc., Beckman Coulter, Inc., Thermo Fisher Scientific, Sysmex Corporation, Abbott, Miltenyi Biotec, Bio-Techne, Agilent Technologies, Inc., and Bio-Rad Laboratories, Inc. are some of the key players operating in this market.
Each of these companies has been profiled in the flow cytometry market report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, and recent developments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 4.4 Bn |
| Market Forecast (Value) in 2031 | US$ 8.8 Bn |
| Growth Rate (CAGR) | 8.0% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Tons | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 4.4 Bn in 2022
It is anticipated to grow at a CAGR of 8.0% from 2023 to 2031
Rise in prevalence of chronic disorders and increase in investment in clinical research
North America was the leading region in 2022
Becton, Dickinson and Company, Merck & Co., Inc., Beckman Coulter, Inc., Thermo Fisher Scientific, Sysmex Corporation, Abbott, Miltenyi Biotec, Bio-Techne, Agilent Technologies, Inc., and Bio-Rad Laboratories, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Flow Cytometry Market
4. Market Overview
4.1. Introduction
4.1.1. Technology Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Flow Cytometry Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Technology/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Flow Cytometry Market Analysis and Forecast, by Technology
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technology, 2017–2031
6.3.1. Cell-based
6.3.2. Bead-based
6.4. Market Attractiveness, by Technology
7. Global Flow Cytometry Market Analysis and Forecast, by Products & Services
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Products & Services, 2017–2031
7.3.1. Reagents & Consumables
7.3.2. Flow Cytometry Instruments
7.3.2.1. Cell Analyzers
7.3.2.2. Cell Sorters
7.3.3. Software
7.3.4. Services
7.3.5. 7.4 Market Attractiveness, by Products & Services
8. Global Flow Cytometry Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Pharmaceutical & Drug Discovery
8.3.2. Diagnostics
8.3.3. Others
8.4. Market Attractiveness, by Application
9. Global Flow Cytometry Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals & Diagnostic Labs
9.3.2. Academic & Research Institutions
9.3.3. Others
9.4. Market Attractiveness, by End-user
10. Global Flow Cytometry Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Flow Cytometry Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Technology, 2017–2031
11.2.1. Cell-based
11.2.2. Bead-based
11.3. Market Attractiveness, by Technology
11.4. Market Value Forecast, by Products & Services, 2017–2031
11.4.1. Reagents & Consumables
11.4.2. Flow Cytometry Instruments
11.4.2.1. Cell Analyzers
11.4.2.2. Cell Sorters
11.4.3. Software
11.4.4. Services
11.5. Market Attractiveness, by Products & Services
11.6. Market Value Forecast, by Application, 2017–2031
11.6.1. Pharmaceutical & Drug Discovery
11.6.2. Diagnostics
11.6.3. Others
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Hospitals & Diagnostic Labs
11.8.2. Academic & Research Institutions
11.8.3. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Technology
11.11.2. By Products & Services
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Flow Cytometry Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Technology, 2017–2031
12.2.1. Cell-based
12.2.2. Bead-based
12.3. Market Attractiveness, by Technology
12.4. Market Value Forecast, by Products & Services, 2017–2031
12.4.1. Reagents & Consumables
12.4.2. Flow Cytometry Instruments
12.4.2.1. Cell Analyzers
12.4.2.2. Cell Sorters
12.4.3. Software
12.4.4. Services
12.5. Market Attractiveness, by Products & Services
12.6. Market Value Forecast, by Application, 2017–2031
12.6.1. Pharmaceutical & Drug Discovery
12.6.2. Diagnostics
12.6.3. Others
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Hospitals & Diagnostic Labs
12.8.2. Academic & Research Institutions
12.8.3. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Technology
12.11.2. By Products & Services
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Flow Cytometry Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Technology, 2017–2031
13.2.1. Cell-based
13.2.2. Bead-based
13.3. Market Attractiveness, by Technology
13.4. Market Value Forecast, by Products & Services, 2017–2031
13.4.1. Reagents & Consumables
13.4.2. Flow Cytometry Instruments
13.4.2.1. Cell Analyzers
13.4.2.2. Cell Sorters
13.4.3. Software
13.4.4. Services
13.5. Market Attractiveness, by Products & Services
13.6. Market Value Forecast, by Application, 2017–2031
13.6.1. Pharmaceutical & Drug Discovery
13.6.2. Diagnostics
13.6.3. Others
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Hospitals & Diagnostic Labs
13.8.2. Academic & Research Institutions
13.8.3. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Technology
13.11.2. By Products & Services
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Flow Cytometry Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Technology, 2017–2031
14.2.1. Cell-based
14.2.2. Bead-based
14.3. Market Attractiveness, by Technology
14.4. Market Value Forecast, by Products & Services, 2017–2031
14.4.1. Reagents & Consumables
14.4.2. Flow Cytometry Instruments
14.4.2.1. Cell Analyzers
14.4.2.2. Cell Sorters
14.4.3. Software
14.4.4. Services
14.5. Market Attractiveness, by Products & Services
14.6. Market Value Forecast, by Application, 2017–2031
14.6.1. Pharmaceutical & Drug Discovery
14.6.2. Diagnostics
14.6.3. Others
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Hospitals & Diagnostic Labs
14.8.2. Academic & Research Institutions
14.8.3. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Technology
14.11.2. By Products & Services
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Flow Cytometry Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Technology, 2017–2031
15.2.1. Cell-based
15.2.2. Bead-based
15.3. Market Attractiveness, by Technology
15.4. Market Value Forecast, by Products & Services, 2017–2031
15.4.1. Reagents & Consumables
15.4.2. Flow Cytometry Instruments
15.4.2.1. Cell Analyzers
15.4.2.2. Cell Sorters
15.4.3. Software
15.4.4. Services
15.5. Market Attractiveness, by Products & Services
15.6. Market Value Forecast, by Application, 2017–2031
15.6.1. Pharmaceutical & Drug Discovery
15.6.2. Diagnostics
15.6.3. Others
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Hospitals & Diagnostic Labs
15.8.2. Academic & Research Institutions
15.8.3. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Technology
15.11.2. By Products & Services
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Becton, Dickinson and Company
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Merck & Co., Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Beckman Coulter, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Sysmex Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Abbott
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Miltenyi Biotec
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Bio-Techne
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Agilent Technologies, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Bio-Rad Laboratories, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Thermo Fisher Scientific
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
List of Tables
Table 01: Global Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 02: Global Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 03: Global Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 05: Global Flow Cytometry Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Flow Cytometry Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 08: North America Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 09: North America Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Flow Cytometry Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 13: Europe Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 14: Europe Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Europe Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Flow Cytometry Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 18: Asia Pacific Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 19: Asia Pacific Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Asia Pacific Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Flow Cytometry Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 23: Latin America Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 24: Latin America Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 25: Latin America Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031
Table 28: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 29: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Flow Cytometry Market Size (US$ Mn), by Region, 2022 and 2031
Figure 02: Global Flow Cytometry Market Revenue (US$ Mn), by Technology, 2022
Figure 03: Global Flow Cytometry Market Value Share, by Technology, 2022
Figure 04: Global Flow Cytometry Market Revenue (US$ Mn), by Products & Services, 2022
Figure 05: Global Flow Cytometry Market Value Share, by Products & Services, 2022
Figure 06: Global Flow Cytometry Market Revenue (US$ Mn), by Application, 2022
Figure 07: Global Flow Cytometry Market Value Share, by Application, 2022
Figure 08: Global Flow Cytometry Market Revenue (US$ Mn), by End-user, 2022
Figure 09: Global Flow Cytometry Market Value Share, by End-user, 2022
Figure 10: Global Flow Cytometry Market Value Share, by Region, 2022
Figure 11: Global Flow Cytometry Market Value (US$ Mn) Forecast, 2017–2031
Figure 12: Global Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031
Figure 13: Global Flow Cytometry Market Attractiveness Analysis, by Technology, 2023-2031
Figure 14: Global Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 15: Global Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023-2031
Figure 16: Global Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031
Figure 17: Global Flow Cytometry Market Attractiveness Analysis, by Application, 2023-2031
Figure 18: Global Flow Cytometry Market Revenue (US$ Mn), by End-user, 2022
Figure 19: Global Flow Cytometry Market Value Share, by End-user, 2022
Figure 20: Global Flow Cytometry Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Flow Cytometry Market Attractiveness Analysis, by Region, 2023-2031
Figure 22: North America Flow Cytometry Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 23: North America Flow Cytometry Market Attractiveness Analysis, by Country, 2023–2031
Figure 24: North America Flow Cytometry Market Value Share Analysis, by Country, 2022 and 2031
Figure 25: North America Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031
Figure 26: North America Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 27: North America Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031
Figure 28: North America Flow Cytometry Market Value Share Analysis, by End-user, 2022 and 2031
Figure 29: North America Flow Cytometry Market Attractiveness Analysis, by Technology, 2023–2031
Figure 30: North America Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023–2031
Figure 31: North America Flow Cytometry Market Attractiveness Analysis, by Application, 2023–2031
Figure 32: North America Flow Cytometry Market Attractiveness Analysis, by End-user, 2023–2031
Figure 33: Europe Flow Cytometry Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 34: Europe Flow Cytometry Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 35: Europe Flow Cytometry Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Europe Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031
Figure 37: Europe Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 38: Europe Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031
Figure 39: Europe Flow Cytometry Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: Europe Flow Cytometry Market Attractiveness Analysis, by Technology, 2023–2031
Figure 41: Europe Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023–2031
Figure 42: Europe Flow Cytometry Market Attractiveness Analysis, by Application, 2023–2031
Figure 43: Europe Flow Cytometry Market Attractiveness Analysis, by End-user, 2023–2031
Figure 44: Asia Pacific Flow Cytometry Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 45: Asia Pacific Flow Cytometry Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 46: Asia Pacific Flow Cytometry Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 47: Asia Pacific Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031
Figure 48: Asia Pacific Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 49: Asia Pacific Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031
Figure 50: Asia Pacific Flow Cytometry Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Asia Pacific Flow Cytometry Market Attractiveness Analysis, by Technology, 2023–2031
Figure 52: Asia Pacific Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023–2031
Figure 53: Asia Pacific Flow Cytometry Market Attractiveness Analysis, by Application, 2023–2031
Figure 54: Asia Pacific Flow Cytometry Market Attractiveness Analysis, by End-user, 2022–2031
Figure 55: Latin America Flow Cytometry Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 56: Latin America Flow Cytometry Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 57: Latin America Flow Cytometry Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 58: Latin America Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031
Figure 59: Latin America Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 60: Latin America Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031
Figure 61: Latin America Flow Cytometry Market Value Share Analysis, by End-user, 2022 and 2031
Figure 62: Latin America Flow Cytometry Market Attractiveness Analysis, by Technology, 2023–2031
Figure 63: Latin America Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023–2031
Figure 64: Latin America Flow Cytometry Market Attractiveness Analysis, by Application, 2023–2031
Figure 65: Latin America Flow Cytometry Market Attractiveness Analysis, by End-user, 2023–2031
Figure 66: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 67: Middle East & Africa Flow Cytometry Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 68: Middle East & Africa Flow Cytometry Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 69: Middle East & Africa Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031
Figure 70: Middle East & Africa Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 71: Middle East & Africa Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031
Figure 72: Middle East & Africa Flow Cytometry Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Middle East & Africa Flow Cytometry Market Attractiveness Analysis, by Technology, 2023–2031
Figure 74: Middle East & Africa Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023–2031
Figure 75: Middle East & Africa Flow Cytometry Market Attractiveness Analysis, by Application, 2023–2031
Figure 76: Middle East & Africa Flow Cytometry Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Flow Cytometry Market
